» Articles » PMID: 34515180

The Protective Effect of Notoginsenoside R1 on Isoflurane-Induced Neurological Impairment in the Rats Via Regulating MiR-29a Expression and Neuroinflammation

Overview
Date 2021 Sep 13
PMID 34515180
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Isoflurane inhalation leads to apoptotic neurodegeneration and further results in learning and cognitive dysfunction. Notoginsenoside R1 (NGR1), a major ingredient from Radix notoginseng, has been reported to exert neuroprotective effect during brain or neuron injury. This study aimed to investigate the effect of NGR1 on neurological impairment.

Methods: Sixty-four male Sprague Dawley rat pups (15-20 g) of postnatal day 7 were recruited. Spatial learning and memory were assessed by the Morris water maze test, and the neurological severity score was determined. Real-time quantitative PCR was used to detect the expression levels of microRNA (miR)-29a. Enzyme-linked immunosorbent assay was applied to estimate the levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the hippocampal tissues.

Results: NGR1 attenuated neurological impairment induced by isoflurane, shown by the decrease in neurological function score and escape latency and the increase in staying time in the original quadrant in rats. NGR1 reversed the downregulation of miR-29a expression induced by isoflurane treatment. After the treatment of NGR1, the elevated levels of IL-6, TNF-α, and IL-1β induced by isoflurane were all decreased significantly in the hippocampal tissues of rats. Additionally, the repressive action of NGR1 in neurological impairment and neuroinflammation was eliminated by downregulating miR-29a in rats.

Conclusion: NGR1 protects against isoflurane-induced neurological impairment. The protective effect of NGR1 might be achieved by promoting the expression of miR-29a and preventing inflammatory response.

Citing Articles

Advancements in research on the effects of panax notoginseng saponin constituents in ameliorating learning and memory disorders.

Liu S, Wang M, Xiao H, Ye J, Cao L, Li W Heliyon. 2024; 10(7):e28581.

PMID: 38586351 PMC: 10998096. DOI: 10.1016/j.heliyon.2024.e28581.


Notoginsenoside R1 promotes Lgr5 stem cell and epithelium renovation in colitis mice via activating Wnt/β-Catenin signaling.

Yu Z, Gao R, Lv C, Geng X, Ren Y, Zhang J Acta Pharmacol Sin. 2024; 45(7):1451-1465.

PMID: 38491161 PMC: 11192909. DOI: 10.1038/s41401-024-01250-7.


Notoginsenoside R1 ameliorates the inflammation induced by amyloid‑β by suppressing SphK1‑mediated NF‑κB activation in PC12 cells.

Wang X, Li B, Yu X, Zhou Y, Wang K, Gao Y Mol Med Rep. 2023; 29(1).

PMID: 38063180 PMC: 10716814. DOI: 10.3892/mmr.2023.13139.


Notoginsenoside R1 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via ERα/GSK-3β/β-catenin signalling pathway.

Lu W, Shi Y, Qian M Int J Exp Pathol. 2023; 105(1):4-12.

PMID: 37899670 PMC: 10797438. DOI: 10.1111/iep.12494.


MicroRNA-424-5p Alleviates Isoflurane Anesthesia-Induced Neurotoxicity in Human Embryonic Stem Cell-Derived Neurons by Targeting FASN.

Gu X, Yue W, Xiu M, Zhang Q, Xie R Comput Math Methods Med. 2022; 2022:2517463.

PMID: 35872948 PMC: 9300301. DOI: 10.1155/2022/2517463.